Ligand Pharmaceuticals Inc (LGNZZ) — SC 13G/A Filings
All SC 13G/A filings from Ligand Pharmaceuticals Inc. Browse 6 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (6)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 8, 2024
- SC 13G/A Filing — Nov 1, 2024
-
Janus Henderson Amends Ligand Pharma Stake Filing
— Feb 13, 2024 Risk: low
Janus Henderson Group plc, an investment advisor, filed an amended Schedule 13G/A on February 13, 2024, indicating its beneficial ownership of Common Stock in L -
Vanguard Group Amends Ligand Pharma Stake to 12.8%
— Feb 13, 2024 Risk: low
The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, disclosing its ownership in Ligand Pharmaceuticals Inc. As of Decem -
BlackRock Trims Ligand Pharma Stake to 6.1%
— Jan 22, 2024
BlackRock, Inc. filed an amended SC 13G/A on January 22, 2024, indicating a change in its ownership of Ligand Pharmaceuticals Incorporated's common stock as of
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX